Inari Medical Inc. (NARI): Price and Financial Metrics


Inari Medical Inc. (NARI): $92.54

2.53 (+2.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NARI POWR Grades


  • NARI scores best on the Sentiment dimension, with a Sentiment rank ahead of 98.75% of US stocks.
  • The strongest trend for NARI is in Stability, which has been heading down over the past 31 weeks.
  • NARI's current lowest rank is in the Stability metric (where it is better than 10.32% of US stocks).

NARI Stock Summary

  • Inari Medical Inc's stock had its IPO on May 22, 2020, making it an older stock than only 0.9% of US equities in our set.
  • The price/operating cash flow metric for Inari Medical Inc is higher than 99.05% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of -97.33%, Inari Medical Inc's debt growth rate surpasses merely 1.46% of about US stocks.
  • Stocks that are quantitatively similar to NARI, based on their financial statements, market capitalization, and price volatility, are ENV, VITL, PINE, GTLS, and TER.
  • Visit NARI's SEC page to see the company's official filings. To visit the company's web site, go to www.inarimedical.com.

NARI Price Target

For more insight on analysts targets of NARI, see our NARI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $129.50 Average Broker Recommendation 1.33 (Strong Buy)

NARI Stock Price Chart Interactive Chart >

Price chart for NARI

NARI Price/Volume Stats

Current price $92.54 52-week high $127.42
Prev. close $90.01 52-week low $44.59
Day low $89.08 Volume 324,131
Day high $93.78 Avg. volume 586,853
50-day MA $95.89 Dividend yield N/A
200-day MA $87.97 Market Cap 4.60B

Inari Medical Inc. (NARI) Company Bio


Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.


NARI Latest News Stream


Event/Time News Detail
Loading, please wait...

NARI Latest Social Stream


Loading social stream, please wait...

View Full NARI Social Stream

Latest NARI News From Around the Web

Below are the latest news stories about Inari Medical Inc that investors may wish to consider to help them evaluate NARI as an investment opportunity.

Inari Medical (NASDAQ:NARI) Is Doing The Right Things To Multiply Its Share Price

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Yahoo | June 15, 2021

Inari Medical Announces Late-Breaking CLOUT Registry Data Demonstrating Long-Term Benefits of Lytic-Free Single-Session Near Bloodless Thrombectomy in First 250 Real-World DVT Patients

Inari Medical CLOUT registry 250 patient 6 mo data Inari Medical CLOUT registry 250 patient 6 mo data IRVINE, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today announced strongly positive interim results of the first 250 deep vein thrombosis (“DVT”) patients enrolled in the ClotTriever Outcomes Registry (“CLOUT”). This lat

Yahoo | June 7, 2021

Inari's Five Levers of Growth According to the CEO

Flawless execution of management's plan could lead to big gains for the stock in the years ahead.

Yahoo | May 26, 2021

Inari Medical, Inc. (NARI) Q1 2021 Earnings Call Transcript

Good day, and thank you for standing by and welcome to the Inari Medical Inc. Q1 2021 earnings conference call.[Operator Instructions] I would now like to hand the conference over to your speaker today, Caroline Corner of investor relations. Joining me on today's call are Bill Hoffman, president and chief executive officer; and Mitch Hill, chief financial officer.

Yahoo | May 12, 2021

Hot Stocks To Watch Or Buy Now: Mutual Funds Like These 5 Top Stocks

A top IPO and big dividend payer are among five market hot stocks big mutual funds are starting positions or increasing their stakes in.

Yahoo | May 4, 2021

Read More 'NARI' Stories Here

NARI Price Returns

1-mo 10.81%
3-mo -14.54%
6-mo 28.94%
1-year 90.80%
3-year N/A
5-year N/A
YTD 6.01%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7642 seconds.